Three-year open protocol continuation study of oral tolerization with myelin antigens in multiple sclerosis and design of a phase III pivotal trial

Ann N Y Acad Sci. 1996 Feb 13:778:243-50. doi: 10.1111/j.1749-6632.1996.tb21132.x.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase III
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Administration, Oral
  • Animals
  • Cattle
  • Double-Blind Method
  • Female
  • Follow-Up Studies
  • Humans
  • Immune Tolerance*
  • Immunotherapy*
  • Male
  • Multiple Sclerosis / immunology
  • Multiple Sclerosis / physiopathology
  • Multiple Sclerosis / therapy*
  • Myelin Sheath / immunology*
  • Research Design
  • Sex Characteristics
  • Treatment Failure